secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2023-03-08T23:59:59+00:00
Accession:  0001493152-23-007004
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros reports FY2022 net revenue $10M; net loss widens to $4.3M; subsidiary SRP winding down
--------------------------------------------------------------------------------

- Net revenue from continuing operations: $10.0M in FY2022 (-2% YoY); Q4 $2.6M (-6% YoY).
- Net loss from continuing operations: $4.3M in FY2022 vs $2.8M loss in 2021; Q4 loss $0.7M flat.
- Gross margins improved to 59% in Q4 (vs 54% prior year); full-year margins 47% (vs 55%).
- Majority-owned subsidiary SRP to wind down after failing to find strategic partner; expects cessation in Q2 2023.
- Cash and equivalents $3.6M at Dec 31, 2022; targeting cash flow breakeven by mid-2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315223007004/0001493152-23-007004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315223007004/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-007004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer